197 related articles for article (PubMed ID: 20512306)
1. [Alpha-melanocyte-stimulating hormone. From bench to bedside].
Böhm M; Luger TA
Hautarzt; 2010 Jun; 61(6):497-504. PubMed ID: 20512306
[TBL] [Abstract][Full Text] [Related]
2. An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria.
Harms J; Lautenschlager S; Minder CE; Minder EI
N Engl J Med; 2009 Jan; 360(3):306-7. PubMed ID: 19144952
[No Abstract] [Full Text] [Related]
3. A review and update on melanocyte stimulating hormone therapy: afamelanotide.
Fabrikant J; Touloei K; Brown SM
J Drugs Dermatol; 2013 Jul; 12(7):775-9. PubMed ID: 23884489
[TBL] [Abstract][Full Text] [Related]
4. Alpha-melanocyte stimulating hormone analogues: the perils and the promise.
Mazza JM; Zippin JH
J Drugs Dermatol; 2009 Aug; 8(8):772-6. PubMed ID: 19663117
[No Abstract] [Full Text] [Related]
5. An α-MSH analog in erythropoietic protoporphyria.
Luger TA; Böhm M
J Invest Dermatol; 2015 Apr; 135(4):929-931. PubMed ID: 25785940
[No Abstract] [Full Text] [Related]
6. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.
Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD
J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432
[TBL] [Abstract][Full Text] [Related]
7. Does alpha-MSH have a role in regulating skin pigmentation in humans?
Thody AJ; Graham A
Pigment Cell Res; 1998 Oct; 11(5):265-74. PubMed ID: 9877097
[TBL] [Abstract][Full Text] [Related]
8. Non-pigmentary actions of alpha-melanocyte-stimulating hormone--lessons from the cutaneous melanocortin system.
Böhm M; Schiller M; Luger TA
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(2):61-8. PubMed ID: 16914088
[TBL] [Abstract][Full Text] [Related]
9. The melanocortin-1 receptor and human pigmentation.
Abdel-Malek Z; Suzuki I; Tada A; Im S; Akcali C
Ann N Y Acad Sci; 1999 Oct; 885():117-33. PubMed ID: 10816645
[TBL] [Abstract][Full Text] [Related]
10. [Alpha-melanocyte-stimulating hormone. Its current significance for dermatology].
Böhm M; Luger TA
Hautarzt; 2004 May; 55(5):436-45. PubMed ID: 15085280
[TBL] [Abstract][Full Text] [Related]
11. alpha-MSH and the regulation of melanocyte function.
Thody AJ
Ann N Y Acad Sci; 1999 Oct; 885():217-29. PubMed ID: 10816655
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of the melanocortin analogue Nle4-D-Phe7-α-MSH in acne vulgaris.
Böhm M; Ehrchen J; Luger TA
J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):108-11. PubMed ID: 22845050
[TBL] [Abstract][Full Text] [Related]
13. Skin POMC peptides: their actions at the human MC-1 receptor and roles in the tanning response.
Tsatmali M; Ancans J; Yukitake J; Thody AJ
Pigment Cell Res; 2000; 13 Suppl 8():125-9. PubMed ID: 11041369
[TBL] [Abstract][Full Text] [Related]
14. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.
Harms JH; Lautenschlager S; Minder CE; Minder EI
Photochem Photobiol; 2009; 85(6):1434-9. PubMed ID: 19656325
[TBL] [Abstract][Full Text] [Related]
15. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.
Luger TA; Brzoska T
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii52-5. PubMed ID: 17934097
[TBL] [Abstract][Full Text] [Related]
16. A bioassay for the detection of neutralizing antibodies against the α-melanocyte stimulating hormone analog afamelanotide in patients with erythropoietic protoporphyria.
Spichty R; Balimann M; Barman J; Minder EI
J Pharm Biomed Anal; 2013 Mar; 75():192-8. PubMed ID: 23277150
[TBL] [Abstract][Full Text] [Related]
17. Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.
Minder EI; Schneider-Yin X
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):43-53. PubMed ID: 25470471
[TBL] [Abstract][Full Text] [Related]
18. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH.
Haylett AK; Nie Z; Brownrigg M; Taylor R; Rhodes LE
Br J Dermatol; 2011 Feb; 164(2):407-14. PubMed ID: 20969564
[TBL] [Abstract][Full Text] [Related]
19. [Nle4-D-Phe7]-alpha-melanocyte-stimulating hormone significantly increased pigmentation and decreased UV damage in fair-skinned Caucasian volunteers.
Barnetson RS; Ooi TK; Zhuang L; Halliday GM; Reid CM; Walker PC; Humphrey SM; Kleinig MJ
J Invest Dermatol; 2006 Aug; 126(8):1869-78. PubMed ID: 16763547
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immunogenicity of the synthetic α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle4-D-Phe7]-α-MSH, Scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies.
Lengweiler S; Kreim S; Barman-Aksözen J; Maurer M; Minder EI
Skin Pharmacol Physiol; 2015; 28(2):103-13. PubMed ID: 25402764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
